`
`Patent No. 9,187,405
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ACT-AVIS ELIZABETH LLC,
`
`Petitioner,
`
`v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`
`Patent Owner.
`
`Case IPR2017—01946
`
`U.S. Patent No. 9,187,405
`
`POWER OF ATTORNEY PURSUANT TO §_ '42.10(b)
`
`Mail Stop Patent "Board
`Patent Trial and Appeal Board
`U.S. Patentand Trademark Office
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`
`
`Case No. IPR2017401946
`
`Patent No. 9,187,405
`
`Novartis AG and Novartis Phannac-eutical's Corporation hereby appoint Jane M, Love,
`
`Ph.D. (Reg. No. 42,812) and Robert W. Trenchard aura hac vice to be filed), both of Gibson,
`
`Dunn & Crutcher LLP, as lead counsel and backup counsel, respectively, to represent. Patent
`
`Owner Novartis Pharmaceuticals Corporation and real party in interest Novartis AG in the inter
`
`partes review proceeding concerning US. Patent No. 9,187,405 before the Patent Trial and
`
`Appeal Board in the United States Patent and Trademark Office, and to transact all business
`
`connected therewith.
`
`Address all communications, emails, and telephone calls to lead and back up counsel
`
`(each associated with the above customer number),-‘as listed below:
`
`Lead COuns‘el:
`
`Back—u u Counsel:
`
`Robert W. Trenchard
`Jane M. Love, PhD.
`
`09m hac vice to be filed)
`USPTO Reg. No. 42,812
`
`
`200 Park Avenue, 47th Floor
`200 Park Avenue, 47th Floor
`
`
`New York, NY 10166
`New York,NY 10166
`
`
`Phone: (212') 351-3942”
`Phone: (212) 351-3922
`
`
`
`Fax: (212) 3 51-5242
`Fax: (212) 3516322
`
`rtrenchard(_@,g_ibsandun'nbdm
`jlove@ gibsondunncom
`
`
`
`
`The undersigned isauthorized to Sign this Power of Attorney on behalf of Novartis AG
`
`and. Novartis Pharmaceuticals Corporation.
`
`
`
`FOR: NOVARTIS AG
`
`Signature:Wt;—
`Nm 4 4‘4 ”WM-M WM
`Authorized Signatory
`
`S CORPORATION
`
`RMACEUT C
`FOR: NOVARTIS P
`%/
`Signature:
`N31116: 9444 Lb)” LK/
`Authorized Signatory
`
`
`
`Date:
`
`9‘ (" / 1
`
`